MedTrace Logo

Evaluation of a Workplace Intervention for Musculoskeletal Disorders Among Blue-collar Workers

NCT07466680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-03-12

No results posted yet for this study

Summary

The goal of this feasibility study is to learn if a work environment program to address musculoskeletal disorders and pain, can be implemented and accepted by employees with physical demanding work tasks. The main question it aims to answer is:

* Will the intervention be accepted by the workers?
* It it feasible to implement a workplace intervention to prevent musculoskeletal disorders and pain?

Participants will:

* Implement the intervention
* Participate in the intervention twice a week for eight weeks
* Answer questionnaires and participate in interviews to evaluate the intervention

Conditions

  • Pain
  • Musculoskeletal Disorders

Interventions

BEHAVIORAL

GLAD intervention

The intervention consists of two components: 1. Implementation of the GLAD intervention to the workers at one unit at the participating workplaces. The GLAD intervention consists of 15 modules containing knowledge on pain, participatory ergonomics and physical exercises. Each module last 30 minutes and are delivered by an occupational safety and health professional (OSH). 2. Education of the OSH's to deliver the GLAD intervention. The education aim to give the OSH the necessary knowledge, skills and competencies to deliver the intervention to the workers at their workplaces. The education program consists of evidence-based knowledge on pain and management, content of the GLAD intervention and implementation strategies. The education is delivered as an online preparatory work (approximately 1 hour) and a 7-hour course with physical attendance.

Sponsors & Collaborators

  • National Research Centre for the Working Environment, Denmark

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-10
Primary Completion
2025-06-27
Completion
2025-06-27

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07466680 on ClinicalTrials.gov